Your browser doesn't support javascript.
loading
In silico Nigellidine (N. sativa) bind to viral spike/active-sites of ACE1/2, AT1/2 to prevent COVID-19 induced vaso-tumult/vascular-damage/comorbidity.
Maiti, Smarajit; Banerjee, Amrita; Kanwar, Mehak.
Afiliación
  • Maiti S; Departmentof Biochemistry and Biotechnology, Cell and Molecular Therapeutics Laboratory, Oriental Institute of Science and Technology, Midnapore, India; Founder and Secretary, Agricure Biotech Research Society, Epidemiology and Human Health Division, Midnapore 721101, India. Electronic address: maitism@rediffmail.com.
  • Banerjee A; Departmentof Biochemistry and Biotechnology, Cell and Molecular Therapeutics Laboratory, Oriental Institute of Science and Technology, Midnapore, India. Electronic address: bamrita.bioinfo@gmail.com.
  • Kanwar M; Departmentof Biochemistry and Biotechnology, Cell and Molecular Therapeutics Laboratory, Oriental Institute of Science and Technology, Midnapore, India.
Vascul Pharmacol ; 138: 106856, 2021 06.
Article en En | MEDLINE | ID: mdl-33746069

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Extractos Vegetales / Nigella sativa / Peptidil-Dipeptidasa A / Receptor de Angiotensina Tipo 1 / Receptor de Angiotensina Tipo 2 / Enzima Convertidora de Angiotensina 2 / COVID-19 Límite: Humans Idioma: En Revista: Vascul Pharmacol Asunto de la revista: ANGIOLOGIA / FARMACOLOGIA Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Extractos Vegetales / Nigella sativa / Peptidil-Dipeptidasa A / Receptor de Angiotensina Tipo 1 / Receptor de Angiotensina Tipo 2 / Enzima Convertidora de Angiotensina 2 / COVID-19 Límite: Humans Idioma: En Revista: Vascul Pharmacol Asunto de la revista: ANGIOLOGIA / FARMACOLOGIA Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos